Brief: Agilon Health Inc Reaffirms Adjusted EBITDA Guidance Of $2 Mln To $7 Mln For Full Year 2022
Jan 9 (Reuters) - agilon health inc AGL.N :
* AGILON HEALTH INC - REAFFIRM ADJUSTED EBITDA GUIDANCE OF
$2
MILLION TO $7 MILLION FOR FULL YEAR 2022
* AGILON HEALTH INC - PROVIDES PRELIMINARY ADJUSTED EBITDA
GUIDANCE OF $75 MILLION TO $90 MILLION FOR FULL YEAR 2023
* AGILON HEALTH INC - PROVIDES PRELIMINARY MEDICARE
ADVANTAGE
MEMBERSHIP OUTLOOK OF ABOVE 400,000 MEMBERS FOR YEAR-END 2023
Source text for Eikon: ID:
Further company coverage: AGL.N
((reuters.briefs@thomsonreuters.com;))
Recent news on Agilon Health
See all newsU.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology
U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise
U.S. STOCKS ON THE MOVE-Albemarle, Howmet, Travere Therapeutics